![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Vat1l | Rat | 1,2-dimethylhydrazine | affects expression | ISO | Vat1l (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of VAT1L mRNA | CTD | PMID:22206623 | Vat1l | Rat | 17beta-estradiol | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Estradiol results in decreased expression of VAT1L mRNA | CTD | PMID:31614463 | Vat1l | Rat | 2,2',5,5'-tetrachlorobiphenyl | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:36804509 | Vat1l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Vat1l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of VAT1L mRNA | CTD | PMID:24680724 | Vat1l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Vat1l (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin affects the methylation of VAT1L intron] which results in increased expression of VAT1L mRNA | CTD | PMID:33017471 | Vat1l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Vat1l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VAT1L mRNA | CTD | PMID:33956508 | Vat1l | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of VAT1L mRNA | CTD | PMID:32109520 | Vat1l | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Vat1l (Mus musculus) | 6480464 | bisphenol S results in decreased expression of VAT1L mRNA | CTD | PMID:30951980 | Vat1l | Rat | 4,4'-sulfonyldiphenol | increases methylation | ISO | VAT1L (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of VAT1L gene | CTD | PMID:31601247 | Vat1l | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Vat1l (Mus musculus) | 6480464 | Fenretinide results in decreased expression of VAT1L mRNA | CTD | PMID:28973697 | Vat1l | Rat | 5-aza-2'-deoxycytidine | affects expression | ISO | VAT1L (Homo sapiens) | 6480464 | Decitabine affects the expression of VAT1L mRNA | CTD | PMID:23300844 | Vat1l | Rat | acrylamide | decreases expression | ISO | Vat1l (Mus musculus) | 6480464 | Acrylamide results in decreased expression of VAT1L mRNA | CTD | PMID:35032568 | Vat1l | Rat | aflatoxin B1 | decreases methylation | ISO | VAT1L (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of VAT1L intron | CTD | PMID:30157460 | Vat1l | Rat | Aflatoxin B2 alpha | increases methylation | ISO | VAT1L (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of VAT1L intron | CTD | PMID:30157460 | Vat1l | Rat | all-trans-retinoic acid | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of VAT1L mRNA | CTD | PMID:21934132 | Vat1l | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of VAT1L mRNA | CTD | PMID:35163327 | Vat1l | Rat | benzo[a]pyrene | decreases methylation | ISO | Vat1l (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased methylation of VAT1L intron | CTD | PMID:27901495 | Vat1l | Rat | benzo[a]pyrene | increases methylation | ISO | VAT1L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of VAT1L exon | CTD | PMID:27901495 | Vat1l | Rat | benzo[a]pyrene | affects methylation | ISO | VAT1L (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of VAT1L intron and Benzo(a)pyrene affects the methylation of VAT1L promoter | CTD | PMID:27901495 and PMID:30157460 | Vat1l | Rat | benzo[e]pyrene | increases methylation | ISO | VAT1L (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of VAT1L intron and benzo(e)pyrene results in increased methylation of VAT1L promoter | CTD | PMID:30157460 | Vat1l | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of VAT1L mRNA | CTD | PMID:31163220 | Vat1l | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of VAT1L protein | CTD | PMID:31163220 | Vat1l | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of VAT1L mRNA | CTD | PMID:30816183 | Vat1l | Rat | bisphenol A | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of VAT1L protein | CTD | PMID:37567409 and PMID:37664457 | Vat1l | Rat | bisphenol A | increases expression | ISO | VAT1L (Homo sapiens) | 6480464 | bisphenol A results in increased expression of VAT1L mRNA | CTD | PMID:29275510 | Vat1l | Rat | carbamazepine | affects expression | ISO | VAT1L (Homo sapiens) | 6480464 | Carbamazepine affects the expression of VAT1L mRNA | CTD | PMID:25979313 | Vat1l | Rat | carmustine | affects response to substance | ISO | VAT1L (Homo sapiens) | 6480464 | VAT1L mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | Vat1l | Rat | chlordecone | affects response to substance | ISO | VAT1L (Homo sapiens) | 6480464 | VAT1L gene SNP affects the susceptibility to Chlordecone | CTD | PMID:25622337 | Vat1l | Rat | cisplatin | affects expression | ISO | VAT1L (Homo sapiens) | 6480464 | Cisplatin affects the expression of VAT1L mRNA | CTD | PMID:23300844 | Vat1l | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of VAT1L mRNA | CTD | PMID:26577399 | Vat1l | Rat | dioxygen | increases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Oxygen deficiency results in increased expression of VAT1L mRNA | CTD | PMID:26516004 | Vat1l | Rat | dorsomorphin | multiple interactions | ISO | VAT1L (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Vat1l | Rat | doxorubicin | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of VAT1L mRNA | CTD | PMID:29803840 | Vat1l | Rat | entinostat | multiple interactions | ISO | VAT1L (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of VAT1L mRNA | CTD | PMID:27188386 | Vat1l | Rat | entinostat | increases expression | ISO | VAT1L (Homo sapiens) | 6480464 | entinostat results in increased expression of VAT1L mRNA | CTD | PMID:26272509 | Vat1l | Rat | epoxiconazole | increases expression | ISO | Vat1l (Mus musculus) | 6480464 | epoxiconazole results in increased expression of VAT1L mRNA | CTD | PMID:35436446 | Vat1l | Rat | ethanol | multiple interactions | ISO | Vat1l (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of VAT1L mRNA | CTD | PMID:30319688 | Vat1l | Rat | lead(0) | affects expression | ISO | VAT1L (Homo sapiens) | 6480464 | Lead affects the expression of VAT1L mRNA | CTD | PMID:28903495 | Vat1l | Rat | lipopolysaccharide | multiple interactions | ISO | VAT1L (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | Vat1l | Rat | methapyrilene | increases methylation | ISO | VAT1L (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of VAT1L intron and Methapyrilene results in increased methylation of VAT1L promoter | CTD | PMID:30157460 | Vat1l | Rat | methylmercury chloride | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of VAT1L mRNA | CTD | PMID:28001369 | Vat1l | Rat | N-methyl-4-phenylpyridinium | increases expression | ISO | Vat1l (Mus musculus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of VAT1L protein | CTD | PMID:26558463 | Vat1l | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of VAT1L mRNA | CTD | PMID:35163327 | Vat1l | Rat | pioglitazone | multiple interactions | ISO | Vat1l (Mus musculus) | 6480464 | [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of VAT1L mRNA | CTD | PMID:27935865 | Vat1l | Rat | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of VAT1L mRNA | CTD | PMID:35811015 | Vat1l | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | VAT1L (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | Vat1l | Rat | SB 431542 | multiple interactions | ISO | VAT1L (Homo sapiens) | 6480464 | [LDN 193189 co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 and PMID:37664457 | Vat1l | Rat | silicon dioxide | increases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of VAT1L mRNA | CTD | PMID:23806026 | Vat1l | Rat | sodium arsenite | affects methylation | ISO | VAT1L (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of VAT1L gene | CTD | PMID:28589171 | Vat1l | Rat | sunitinib | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of VAT1L mRNA | CTD | PMID:31533062 | Vat1l | Rat | temozolomide | affects response to substance | ISO | VAT1L (Homo sapiens) | 6480464 | VAT1L mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | Vat1l | Rat | temozolomide | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of VAT1L mRNA | CTD | PMID:31758290 | Vat1l | Rat | titanium dioxide | decreases expression | ISO | Vat1l (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of VAT1L mRNA | CTD | PMID:23557971 | Vat1l | Rat | trichostatin A | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of VAT1L mRNA | CTD | PMID:24935251 and PMID:26272509 | Vat1l | Rat | trichostatin A | multiple interactions | ISO | VAT1L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VAT1L mRNA | CTD | PMID:27188386 | Vat1l | Rat | triclosan | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Triclosan results in decreased expression of VAT1L mRNA | CTD | PMID:30510588 | Vat1l | Rat | trimellitic anhydride | increases expression | ISO | Vat1l (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of VAT1L mRNA | CTD | PMID:19042947 | Vat1l | Rat | valproic acid | increases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of VAT1L mRNA | CTD | PMID:19101580 more ... | Vat1l | Rat | valproic acid | affects expression | ISO | VAT1L (Homo sapiens) | 6480464 | Valproic Acid affects the expression of VAT1L mRNA | CTD | PMID:25979313 | Vat1l | Rat | valproic acid | decreases expression | ISO | VAT1L (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of VAT1L mRNA | CTD | PMID:23179753 and PMID:26272509 | Vat1l | Rat | valproic acid | multiple interactions | ISO | VAT1L (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of VAT1L mRNA | CTD | PMID:27188386 | |